Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Heinz Diehl"'
Autor:
Elaine Beller, Justin Clark, Guy Tsafnat, Clive Adams, Heinz Diehl, Hans Lund, Mourad Ouzzani, Kristina Thayer, James Thomas, Tari Turner, Jun Xia, Karen Robinson, Paul Glasziou, On behalf of the founding members of the ICASR group
Publikováno v:
Systematic Reviews, Vol 7, Iss 1, Pp 1-7 (2018)
Abstract Systematic reviews (SR) are vital to health care, but have become complicated and time-consuming, due to the rapid expansion of evidence to be synthesised. Fortunately, many tasks of systematic reviews have the potential to be automated or m
Externí odkaz:
https://doaj.org/article/dc9780ae339e476c8fb0e24fcd43388d
Publikováno v:
Diehl, H, Graverholt, B, Espehaug, B & Lund, H 2016, ' Implementing guidelines in nursing homes : a systematic review ', BMC Health Services Research, vol. 16, 298 . https://doi.org/10.1186/s12913-016-1550-z
BMC Health Services Research
BMC Health Services Research
Background Research on guideline implementation strategies has mostly been conducted in settings which differ significantly from a nursing home setting and its transferability to the nursing home setting is therefore limited. The objective of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce09ea15bcea7e123434100bfb11a0c
https://findresearcher.sdu.dk:8443/ws/files/121041041/Implementing_guidelines_in_nursing_homes.pdf
https://findresearcher.sdu.dk:8443/ws/files/121041041/Implementing_guidelines_in_nursing_homes.pdf
Autor:
Karl-Heinz Diehl, David Smith, Jean-Marc Vidal, Rudolf Pfister, Cor Van De Vorstenbosch, Robin Hull, Yvon Rabemampianina, David B. Morton
Publikováno v:
Journal of Applied Toxicology. 21:15-23
This article is the result of an initiative between the European Federation of Pharmaceutical Industries Associations (EFPIA) and the European Centre for the Validation of Alternative Methods (ECVAM). Its objectives are to provide the researcher in t
Autor:
Martin Reers, Dieter Dr Hoffmann, Dirk Seiffge, Karl Heinz Diehl, Ernst Weinmann, Gerhard Dickneite, Jörg Czech, Werner Stüber
Publikováno v:
Thrombosis Research. 77:357-368
The new thrombin inhibitor CRC 220 was characterized in vivo for its antithrombotic effects. CRC 220 led to a dose-dependent prolongation of clotting parameters as determined in rats, rabbits, dogs, sheeps, pigs and monkeys. We evaluated the efficacy
Autor:
Andreas Jessel, Berndt Hein, Hansjörg Ronneberger, Eric-Paul Pâques, Karl-Heinz Diehl, Jürgen Römisch
Publikováno v:
Haemostasis. 25(4)
The specific thrombin inhibitor r-hirudin (HBW 023) has been demonstrated to be effective in preventing thrombosis in preclinical models. Up to now, no bleeding complications have been observed using therapeutically effective doses in animal studies.
Autor:
Martin Reers, Dieter Hoffmann, Jürgen Römisch, Ute Krahl-Mateblowski, Werner Stüber, Eric-Paul Pâques, Karl-Heinz Diehl
Publikováno v:
Haemostasis. 23(5)
Recombinant hirudin and a shortened synthetic analogue, with the amino acid sequence of D-Phe-Pro-Arg-Pro-(Gly)4-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu, are specific thrombin inhibitors which in a concentration-dependent manner inhibit throm